In Conversation With, Ron Borsheim, Vice President at BTL Industries (EMSCULPT NEO)

With the introduction of EMSCULPT NEO to S-Thetics Clinic, I’d like to bring you behind the technology, to discover more about the years of extensive clinical research and science behind this world-first body-shaping technology.


As a former NHS Surgeon and a qualified Doctor for over 22 years now, I always look at any new technology or treatment with a healthy degree of cynicism.

Backed By Science

The original EMSCULPT was approved in 2016, however BTL took a further 16 months to conduct 7 clinical studies, before bringing it to market, to ensure they had robust clinical data in place.

There are now 30 scientific publications since 2018 on the HIFEM technology used in EMSCULPT NEO, making this the most intensively researched and clinically validated technology used in non-invasive body shaping.


In Conversation With Ron Borsheim

I had the pleasure of speaking with Ron Borsheim, a key figure in the creation, research and development of EMSCULPT NEO and its HIFEM technology.

Ron is Vice President of New Business Development at BTL Industries, based in the USA. BTL are the company who developed and brought the original EMSCULPT to market, one of the most innovative and disruptive technologies in non-surgical body contouring, which created a new treatment category by simultaneously reducing fat and building muscle.

Ron has vast experience in surgical, ophthalmic and aesthetic technologies, as well as, orthopedic, gynecology, urology, ophthalmic, radiation oncology and cosmetic procedures.

Miss-Sherina-Balaratnam-In Conversation-With-Ron-Borsheim-Vice-President-BTL-Industries-EMSCULPT-NEO-at-S-Thetics-Clinic-Beaconsfield

A senior leader in global aesthetics, Ron has founded and shaped many of the key technologies we use today, including Smart Lipo and a range of non-surgical innovations.

Miss-Sherina-Balaratnam-In Conversation-With-Ron-Borsheim-Vice-President-BTL-Industries-EMSCULPT-NEO-available-at-S-Thetics-Clinic

Our topics of conversation include:

✔️ The story behind BTL and how this background of sports science led to the introduction of EMSculpt
✔️ The clinical studies and robust data that underpins EMSCULPT NEO and its multiple FDA approvals
✔️ What is HIFEM technology (now HIFEM+ in NEO) and how does it work
✔️ Future trends and innovations in non-surgical body contouring and how EMSCULPT NEO continues to evolve as the category leader

Thank you to Ron for your time and sharing your expertise with our audience.


To find out how you could benefit from EMSCULPT NEO® treatments in our dedicated body suite to build muscle and burn fat, please contact our team on:

01494 670 990 or